Skip to main content
. 2013 Mar 20;304(10):R846–R853. doi: 10.1152/ajpregu.00585.2012

Fig. 5.

Fig. 5.

Treatment with U0126 (30 mg/kg), an inhibitor of ERK1/2 phosphorylation, attenuated the increase of bladder weight (A) and the reduction in mechanical sensitivity threshold-induced by acrolein (B). n = 6. *P < 0.05, **P < 0.01 vs. saline-treated, respectively. #P < 0.05 vs. acrolein-treated.